Cardioprotection and Thyroid Hormones in the Clinical Setting of Heart Failure
Ischemic heart disease is the main cause of morbidity and mortality worldwide and is becoming more widespread with population aging. Cardioprotection is a dynamic process characterized by mechanisms related to myocardial damage and activation of protective factors. Targeting these processes could be...
Main Authors: | Francesca Mastorci, Laura Sabatino, Cristina Vassalle, Alessandro Pingitore |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00927/full |
Similar Items
-
Thyroid and Heart: A Fatal Pathophysiological Attraction in a Controversial Clinical Liaison
by: Alessandro Pingitore, et al.
Published: (2023-11-01) -
Cardioprotection by Hypothyroidism Is Not Mediated by Favorable Hemodynamics—Role of Canonical Thyroid Hormone Receptor Alpha Signaling
by: Janina Pape, et al.
Published: (2022-11-01) -
Nrf2-Mediated Antioxidant Defense and Thyroid Hormone Signaling: A Focus on Cardioprotective Effects
by: Laura Sabatino
Published: (2023-05-01) -
Main Factors Involved in Thyroid Hormone Action
by: Lorena Tedeschi, et al.
Published: (2021-12-01) -
Assessment of thyroid hormones, insulin and magnesium in dairy cattle with subclinical ketosis
by: A Sadeghi-nasab, et al.
Published: (2011-08-01)